Brian Lewis to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Brian Lewis has written about Carcinoma, Hepatocellular.
Connection Strength
1.116
-
Chen YW, Chu HC, Shiah WJ, Chou CP, Klimstra DS, Lewis BC. p16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cells. PLoS One. 2013; 8(7):e69389.
Score: 0.364
-
Chen YW, Boyartchuk V, Lewis BC. Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells. Neoplasia. 2009 Sep; 11(9):835-45.
Score: 0.278
-
Chen YW, Paliwal S, Draheim K, Grossman SR, Lewis BC. p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein. Cancer Res. 2008 Jan 15; 68(2):476-82.
Score: 0.248
-
Lewis BC, Klimstra DS, Socci ND, Xu S, Koutcher JA, Varmus HE. The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma. Mol Cell Biol. 2005 Feb; 25(4):1228-37.
Score: 0.202
-
Wang J, Park JS, Wei Y, Rajurkar M, Cotton JL, Fan Q, Lewis BC, Ji H, Mao J. TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPa function. Mol Cell. 2013 Jul 25; 51(2):211-25.
Score: 0.023